Cd47-Sirpα Interaction and IL-10 Constrain Inflammation-induced Macrophage Phagocytosis of Healthy Self-cells
Overview
Authors
Affiliations
Rapid clearance of adoptively transferred Cd47-null (Cd47(-/-)) cells in congeneic WT mice suggests a critical self-recognition mechanism, in which CD47 is the ubiquitous marker of self, and its interaction with macrophage signal regulatory protein α (SIRPα) triggers inhibitory signaling through SIRPα cytoplasmic immunoreceptor tyrosine-based inhibition motifs and tyrosine phosphatase SHP-1/2. However, instead of displaying self-destruction phenotypes, Cd47(-/-) mice manifest no, or only mild, macrophage phagocytosis toward self-cells except under the nonobese diabetic background. Studying our recently established Sirpα-KO (Sirpα(-/-)) mice, as well as Cd47(-/-) mice, we reveal additional activation and inhibitory mechanisms besides the CD47-SIRPα axis dominantly controlling macrophage behavior. Sirpα(-/-) mice and Cd47(-/-) mice, although being normally healthy, develop severe anemia and splenomegaly under chronic colitis, peritonitis, cytokine treatments, and CFA-/LPS-induced inflammation, owing to splenic macrophages phagocytizing self-red blood cells. Ex vivo phagocytosis assays confirmed general inactivity of macrophages from Sirpα(-/-) or Cd47(-/-) mice toward healthy self-cells, whereas they aggressively attack toward bacteria, zymosan, apoptotic, and immune complex-bound cells; however, treating these macrophages with IL-17, LPS, IL-6, IL-1β, and TNFα, but not IFNγ, dramatically initiates potent phagocytosis toward self-cells, for which only the Cd47-Sirpα interaction restrains. Even for macrophages from WT mice, phagocytosis toward Cd47(-/-) cells does not occur without phagocytic activation. Mechanistic studies suggest a PKC-Syk-mediated signaling pathway, to which IL-10 conversely inhibits, is required for activating macrophage self-targeting, followed by phagocytosis independent of calreticulin Moreover, we identified spleen red pulp to be one specific tissue that provides stimuli constantly activating macrophage phagocytosis albeit lacking in Cd47(-/-) or Sirpα(-/-) mice.
The Physiological and Therapeutic Role of CD47 in Macrophage Function and Cancer.
Bess S, Igoe M, Muldoon T Immunol Invest. 2024; 54(1):112-146.
PMID: 39415597 PMC: 11774679. DOI: 10.1080/08820139.2024.2415409.
Deciphering the role of CD47 in cancer immunotherapy.
Liu Y, Weng L, Wang Y, Zhang J, Wu Q, Zhao P J Adv Res. 2024; 63:129-158.
PMID: 39167629 PMC: 11380025. DOI: 10.1016/j.jare.2023.10.009.
LEstrange-Stranieri E, Gottschalk T, Wright M, Hibbs M Front Immunol. 2024; 15:1395427.
PMID: 39007135 PMC: 11239442. DOI: 10.3389/fimmu.2024.1395427.
Banerjee R, Meyer T, Cam M, Kaur S, Roberts D Elife. 2024; 12.
PMID: 38979889 PMC: 11233134. DOI: 10.7554/eLife.92679.
The Immune Response of Cancer Cells in Breast and Gynecologic Neoplasms.
Rakoczy K, Kaczor J, Soltyk A, Szymanska N, Stecko J, Drag-Zalesinska M Int J Mol Sci. 2024; 25(11).
PMID: 38892394 PMC: 11172873. DOI: 10.3390/ijms25116206.